Company Profile
Frontage provides drug discovery, drug development, pharmaceutical product development, and laboratory testing services to pharmaceutical, biotechnology, and agrochemical companies.
It offers drug discovery services comprising medicinal chemistry, pharmacology, and efficacy, as well as absorption, distribution, metabolism, and excretion (ADME) screening drug metabolism and pharmacokinetics (DMPK).
Its portfolio also includes safety and toxicology, early phase clinical services, and bioequivalence and related services, such as pharmacology, medical writing, and regulatory support.
Additionally, it offers pharmaceutical product development services, including intermediate and active pharmaceutical ingredient (API) synthesis, process and formulation development, and clinical trial material manufacturing
Laboratory testing services, such as bioanalysis, biomarkers, genomics, chemistry, manufacturing and controls (ยCMCย) analytical testing, and central laboratory services. It operates in the United States, Canada, the People's Republic of China, Europe, India, Japan, South Korea, and Australia. Founded in 2001, the company is headquartered in Exton, Pennsylvania. Frontage Holdings Corporation operates as a subsidiary of Hongkong Tigermed Consulting Co., ltd.